More information: Hannah L. Cornman et al, Targeted dual biologic therapy for erythroderma of unknown etiology guided by high-parameter peripheral blood immunophenotyping, Scientific Reports (2025 ...

BioIVT provides isolated peripheral blood mononuclear cells ... of at least 70% and purity of at least 85% are confirmed via flow cytometry analysis.

The following is a summary of “Recall vaccination increases detectable B-cell reactivity in persons with multiple sclerosis treated with ocrelizumab,” published in the April 2025 issue of Journal of ...